{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:09:40Z","timestamp":1770750580562,"version":"3.50.0"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Neurofascin 186 autoantibodies are known to occur with a diseased peripheral nervous system. Recently, also additional central nervous system (CNS) involvement has been reported in conjunction with neurofascin 186 autoantibodies. Our case enlarges the spectrum of neurofascin 186 antibody-related disease to include mild cognitive impairment (MCI).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We report here a case after having examined the patient files retrospectively, including diagnostics such as blood and cerebrospinal fluid (CSF) analysis involving the determination of neural autoantibodies, brain magnetic resonance imaging (MRI), brain fluorodesoxyglucose positron emission tomography (FDG-PET), and extensive neuropsychological testing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We report on two patients with MCI. Brain MRI showed cerebral microangiopathy in both patients, but brain FDG-PET demonstrated pathology in the right prefrontal cortex, in the right inferior parietal cortex, and in both lateral occipital cortices in one patient. Neurofascin 186 antibodies were detected in serum in both patients, and neurofascin 186 autoantibodies were also detected in the CSF of one of these patients. At follow-up six month later, neurofascin 186 autoantibodies disappeared in one patient while persisting in the other.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We report on two individuals presenting MCI associated with neurofascin 186 antibodies, thus expanding the potential spectrum of neurofascin 186-associated disease. This report supports the recommendation to consider also neurofascin 186 autoantibodies in not just peripheral nerve disease, but also in disorders involving CNS autoimmunity. More studies are needed to clarify the lack of association between neurofascin 186 autoantibodies and cognitive decline.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2022.1054461","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T05:07:58Z","timestamp":1673500078000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Case report: Amnestic mild cognitive impairment in multiple domains associated with neurofascin 186 autoantibodies: Case series with follow-up and review"],"prefix":"10.3389","volume":"13","author":[{"given":"Niels","family":"Hansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Sagebiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Rentzsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sina","family":"Hirschel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Wiltfang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn H.","family":"Schott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bartels","family":"Claudia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1212\/WNL.0b013e31827689ad","article-title":"Neurofascin as a target for autoantibodies in peripheral neuropathies.","volume":"79","author":"Ng","year":"2012","journal-title":"Neurology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1093\/brain\/awx124","article-title":"Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy.","volume":"140","author":"Delmont","year":"2017","journal-title":"Brain."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy134","article-title":"Subacute nodopathy with conduction blocks and anti-neurofascin 140\/186 antibodies: an ultrastructural study.","volume":"141","author":"Vallat","year":"2018","journal-title":"Brain."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-022-01989-y","article-title":"Anti-neurofascin 186 antibody in amyotrophic lateral sclerosis: a case report.","author":"Liu","year":"2022","journal-title":"Acta Neurol Belg."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.1007\/s10072-021-05101-9","article-title":"From PNS to CNS: characteristics of anti-neurofascin 186 neuropathy in 16 cases.","volume":"42","author":"Xie","year":"2021","journal-title":"Neurol Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.neuron.2016.08.015","article-title":"Dual function of NRP1 in axon guidance and subcellular target recognition in cerebellum.","volume":"91","author":"Telley","year":"2016","journal-title":"Neuron."},{"key":"B7","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1007\/s12311-022-01422-3","article-title":"A liaison brought to light: cerebellum-hippocampus, partners for spatial cognition.","volume":"21","author":"Rondi-Reig","year":"2022","journal-title":"Cerebellum."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1084\/jem.20071053","article-title":"Neurofascin as a novel target for autoantibody-mediated axonal injury.","volume":"204","author":"Mathey","year":"2007","journal-title":"J Exp Med."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2018.12.011","article-title":"Anti-neurofascin autoantibody and demyelination.","volume":"130","author":"Kira","year":"2019","journal-title":"Neurochem Int."},{"key":"B10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jns.2016.03.004","article-title":"Prevalence of neurofascin-155 antibodies in patients with multiple sclerosis.","volume":"364","author":"Stich","year":"2016","journal-title":"J Neurol Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/003591576505800503","article-title":"The environment and disease: association or causation?.","volume":"58","author":"Hill","year":"1965","journal-title":"Proc R Soc Med."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2020.100154","article-title":"Autoantibody-associated psychiatric symptoms and syndromes in adults: a narrative review and proposed diagnostic approach","volume":"9","author":"Hansen","year":"2020","journal-title":"Brain Behav Immun Health"},{"key":"B13","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/jns.12465","article-title":"Report of a fulminant anti-pan-neurofascin-associated neuropathy responsive to rituximab and bortezomib.","volume":"26","author":"Fels","year":"2021","journal-title":"Peripher Nerv Syst."},{"key":"B14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.nmd.2022.01.006","article-title":"Autoantibody profile in a Malaysian cohort of chronic inflammatory demyelinating polyneuropathy.","volume":"32","author":"Tan","year":"2022","journal-title":"Neuromuscul Disord."},{"key":"B15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1529-8027.2012.00372.x","article-title":"Nodal proteins are target antigens in guillain-barr\u00e9 syndrome","volume":"17","author":"Devaux","year":"2012","journal-title":"J Peripher Nerv Syst"},{"key":"B16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jneuroim.2014.09.001","article-title":"Autoantibodies to neurofascin-186 and gliomedin in multifocal motor neuropathy.","volume":"276","author":"Notturno","year":"2014","journal-title":"J Neuroimmunol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2017.00724","article-title":"Neurofascin (NF)155- and NF186-specific T cell response in a patient developing a central pontocerebellar demyelination after 10 years of CIDP.","volume":"8","author":"Klehmet","year":"2017","journal-title":"Front Neurol."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.1054461\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T05:08:00Z","timestamp":1673500080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.1054461\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":17,"alternative-id":["10.3389\/fpsyt.2022.1054461"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2022.1054461","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,12]]},"article-number":"1054461"}}